Grant: Idea to Innovation
University of Toronto
$125,000.00
Smart Capsule for non-invasive targeted sampling and delivery in the gut
FY 2022-23
Summary
We have developed a prototype magnetically-actuated capsule which can take samples wirelessly on demand from within the gastrointestinal (GI) tract. This capsule has a sample chamber and is activated wirelessly using a safe low-strength magnetic field. The operation is simpler than other robotic capsule endoscopes and does not rely on complex control systems or mechanisms but instead has a simple operation using a permanent magnet outside the body to activate the capsule. Following ingestion, the capsule position is tracked and once it reaches the location of interest within the small intestine, it is briefly opened using the magnetic field to collect a sample. After the field is removed, the capsule naturally closes and seals tightly, to be excreted for collection and sample analysis.We have shown that this capsule has robust sealing and reliable sampling activation, which we have tested in both laboratory and in-vivo field conditions. In initial animal trials, we have shown the device can be wirelessly activated within the stomach of live pigs. In this one-year I2I Phase I project, we aim to build on these discoveries to address two key challenges to the successful commercialization of our device. 1) We will refine our protocol and conduct two sets of live dog trials (each with 3 dogs) to prove the capsule can be used to sample/delivery anywhere within the GI tract. 2) Developing Next Generation Capsule with Localization Capability. For many use cases, the location of the capsule must be known prior to activation. While medical imaging (ultrasound, X-Ray fluoroscopy) can observe the capsule, we have developed a prototype magnetic localization method which takes advantage of the magnets already integrated into the capsule. The patient would wear a vest of magnetic sensors which will be used to calculate the position of the capsule within the body to an accuracy of less than 2 cm.
Program
Idea to Innovation
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
571961-2022
Name nom
Diller, Eric ED
Department département
Mechanical and Industrial Engineering
Organization id
31
Institution établissement
University of Toronto
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2022
Competition year année de concours
2022
Award amount
125000
Program id
I2IPJ
Program name en
Idea to Innovation
Program name fr
De l'idée à l'innovation
Group en
RESEARCH PARTNERSHIPS
Group fr
PARTENARIATS DE RECHERCHE
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
1101
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Human health (including medically-related psychological research)
Area of application fr
Santé publique (y compris recherche psychologique liée à la médecine)
Research subject code
1901
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomedical technology
Research subject fr
Technologie biomédicale
Installment
inst:1
Partie
1
Nb partie
1
Application title
Smart Capsule for non-invasive targeted sampling and delivery in the gut
Application summary
We have developed a prototype magnetically-actuated capsule which can take samples wirelessly on demand from within the gastrointestinal (GI) tract. This capsule has a sample chamber and is activated wirelessly using a safe low-strength magnetic field. The operation is simpler than other robotic capsule endoscopes and does not rely on complex control systems or mechanisms but instead has a simple operation using a permanent magnet outside the body to activate the capsule. Following ingestion, the capsule position is tracked and once it reaches the location of interest within the small intestine, it is briefly opened using the magnetic field to collect a sample. After the field is removed, the capsule naturally closes and seals tightly, to be excreted for collection and sample analysis.We have shown that this capsule has robust sealing and reliable sampling activation, which we have tested in both laboratory and in-vivo field conditions. In initial animal trials, we have shown the device can be wirelessly activated within the stomach of live pigs. In this one-year I2I Phase I project, we aim to build on these discoveries to address two key challenges to the successful commercialization of our device. 1) We will refine our protocol and conduct two sets of live dog trials (each with 3 dogs) to prove the capsule can be used to sample/delivery anywhere within the GI tract. 2) Developing Next Generation Capsule with Localization Capability. For many use cases, the location of the capsule must be known prior to activation. While medical imaging (ultrasound, X-Ray fluoroscopy) can observe the capsule, we have developed a prototype magnetic localization method which takes advantage of the magnets already integrated into the capsule. The patient would wear a vest of magnetic sensors which will be used to calculate the position of the capsule within the body to an accuracy of less than 2 cm.